| Dataset | w1a_vs_wt_vs_wt.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp_repos |
| Phenotype | w1a_vs_wt.cls#ago1w1a_versus_ago1gfp_repos |
| Upregulated in class | ago1w1a |
| GeneSet | KEGG_PATHWAYS_IN_CANCER |
| Enrichment Score (ES) | 0.3408451 |
| Normalized Enrichment Score (NES) | 1.4297991 |
| Nominal p-value | 0.0013927576 |
| FDR q-value | 0.24870817 |
| FWER p-Value | 0.988 |

| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | IL6 | NA | IL6 Entrez,  Source | interleukin 6 (interferon, beta 2) | 17 | 4.596 | 0.0224 | Yes |
| 2 | TRAF1 | NA | TRAF1 Entrez,  Source | TNF receptor-associated factor 1 | 89 | 3.323 | 0.0353 | Yes |
| 3 | PLCG2 | NA | PLCG2 Entrez,  Source | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 92 | 3.302 | 0.0520 | Yes |
| 4 | LAMA4 | NA | LAMA4 Entrez,  Source | laminin, alpha 4 | 124 | 2.938 | 0.0651 | Yes |
| 5 | TCF7L1 | NA | TCF7L1 Entrez,  Source | transcription factor 7-like 1 (T-cell specific, HMG-box) | 132 | 2.849 | 0.0792 | Yes |
| 6 | NFKB2 | NA | NFKB2 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 138 | 2.804 | 0.0932 | Yes |
| 7 | FGF2 | NA | FGF2 Entrez,  Source | fibroblast growth factor 2 (basic) | 142 | 2.778 | 0.1071 | Yes |
| 8 | ITGA2 | NA | ITGA2 Entrez,  Source | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 148 | 2.720 | 0.1207 | Yes |
| 9 | BIRC3 | NA | BIRC3 Entrez,  Source | baculoviral IAP repeat-containing 3 | 182 | 2.484 | 0.1314 | Yes |
| 10 | HSP90B1 | NA | HSP90B1 Entrez,  Source | heat shock protein 90kDa beta (Grp94), member 1 | 196 | 2.412 | 0.1430 | Yes |
| 11 | FGF1 | NA | FGF1 Entrez,  Source | fibroblast growth factor 1 (acidic) | 214 | 2.335 | 0.1539 | Yes |
| 12 | PML | NA | PML Entrez,  Source | promyelocytic leukemia | 307 | 1.956 | 0.1587 | Yes |
| 13 | LAMB3 | NA | LAMB3 Entrez,  Source | laminin, beta 3 | 343 | 1.846 | 0.1661 | Yes |
| 14 | PIK3R1 | NA | PIK3R1 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) | 366 | 1.786 | 0.1739 | Yes |
| 15 | CSF2RA | NA | CSF2RA Entrez,  Source | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 431 | 1.652 | 0.1787 | Yes |
| 16 | FZD4 | NA | FZD4 Entrez,  Source | frizzled homolog 4 (Drosophila) | 449 | 1.610 | 0.1860 | Yes |
| 17 | NFKBIA | NA | NFKBIA Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 460 | 1.595 | 0.1935 | Yes |
| 18 | WNT7B | NA | WNT7B Entrez,  Source | wingless-type MMTV integration site family, member 7B | 468 | 1.586 | 0.2012 | Yes |
| 19 | FZD8 | NA | FZD8 Entrez,  Source | frizzled homolog 8 (Drosophila) | 496 | 1.541 | 0.2075 | Yes |
| 20 | BCL2L1 | NA | BCL2L1 Entrez,  Source | BCL2-like 1 | 512 | 1.526 | 0.2144 | Yes |
| 21 | DAPK1 | NA | DAPK1 Entrez,  Source | death-associated protein kinase 1 | 556 | 1.477 | 0.2195 | Yes |
| 22 | TGFB2 | NA | TGFB2 Entrez,  Source | transforming growth factor, beta 2 | 589 | 1.429 | 0.2250 | Yes |
| 23 | TGFB1 | NA | TGFB1 Entrez,  Source | transforming growth factor, beta 1 (Camurati-Engelmann disease) | 593 | 1.425 | 0.2320 | Yes |
| 24 | PAX8 | NA | PAX8 Entrez,  Source | paired box gene 8 | 682 | 1.335 | 0.2339 | Yes |
| 25 | FGF21 | NA | FGF21 Entrez,  Source | fibroblast growth factor 21 | 716 | 1.313 | 0.2387 | Yes |
| 26 | JUN | NA | JUN Entrez,  Source | jun oncogene | 718 | 1.312 | 0.2453 | Yes |
| 27 | COL4A2 | NA | COL4A2 Entrez,  Source | collagen, type IV, alpha 2 | 794 | 1.252 | 0.2475 | Yes |
| 28 | FN1 | NA | FN1 Entrez,  Source | fibronectin 1 | 803 | 1.244 | 0.2533 | Yes |
| 29 | RXRG | NA | RXRG Entrez,  Source | retinoid X receptor, gamma | 894 | 1.179 | 0.2543 | Yes |
| 30 | LAMC2 | NA | LAMC2 Entrez,  Source | laminin, gamma 2 | 917 | 1.160 | 0.2589 | Yes |
| 31 | ITGA3 | NA | ITGA3 Entrez,  Source | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 961 | 1.138 | 0.2623 | Yes |
| 32 | EGFR | NA | EGFR Entrez,  Source | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 1042 | 1.098 | 0.2634 | Yes |
| 33 | PDGFA | NA | PDGFA Entrez,  Source | platelet-derived growth factor alpha polypeptide | 1146 | 1.048 | 0.2630 | Yes |
| 34 | RELA | NA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 1150 | 1.047 | 0.2681 | Yes |
| 35 | DVL1 | NA | DVL1 Entrez,  Source | dishevelled, dsh homolog 1 (Drosophila) | 1298 | 0.983 | 0.2649 | Yes |
| 36 | LAMA5 | NA | LAMA5 Entrez,  Source | laminin, alpha 5 | 1326 | 0.975 | 0.2683 | Yes |
| 37 | FADD | NA | FADD Entrez,  Source | Fas (TNFRSF6)-associated via death domain | 1402 | 0.946 | 0.2689 | Yes |
| 38 | PIAS4 | NA | PIAS4 Entrez,  Source | protein inhibitor of activated STAT, 4 | 1445 | 0.931 | 0.2713 | Yes |
| 39 | BCR | NA | BCR Entrez,  Source | breakpoint cluster region | 1496 | 0.911 | 0.2731 | Yes |
| 40 | CREBBP | NA | CREBBP Entrez,  Source | CREB binding protein (Rubinstein-Taybi syndrome) | 1528 | 0.903 | 0.2760 | Yes |
| 41 | CCNA1 | NA | CCNA1 Entrez,  Source | cyclin A1 | 1571 | 0.891 | 0.2781 | Yes |
| 42 | PIK3CD | NA | PIK3CD Entrez,  Source | phosphoinositide-3-kinase, catalytic, delta polypeptide | 1572 | 0.890 | 0.2827 | Yes |
| 43 | IKBKG | NA | IKBKG Entrez,  Source | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 1587 | 0.884 | 0.2864 | Yes |
| 44 | FAS | NA | FAS Entrez,  Source | Fas (TNF receptor superfamily, member 6) | 1600 | 0.881 | 0.2902 | Yes |
| 45 | EGLN2 | NA | EGLN2 Entrez,  Source | egl nine homolog 2 (C. elegans) | 1730 | 0.844 | 0.2872 | Yes |
| 46 | RAC2 | NA | RAC2 Entrez,  Source | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 1748 | 0.839 | 0.2905 | Yes |
| 47 | NFKB1 | NA | NFKB1 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 1767 | 0.835 | 0.2938 | Yes |
| 48 | HRAS | NA | HRAS Entrez,  Source | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 1799 | 0.831 | 0.2963 | Yes |
| 49 | COL4A1 | NA | COL4A1 Entrez,  Source | collagen, type IV, alpha 1 | 1818 | 0.825 | 0.2994 | Yes |
| 50 | FGFR1 | NA | FGFR1 Entrez,  Source | fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | 1820 | 0.825 | 0.3036 | Yes |
| 51 | HSP90AB1 | NA | HSP90AB1 Entrez,  Source | heat shock protein 90kDa alpha (cytosolic), class B member 1 | 1912 | 0.805 | 0.3026 | Yes |
| 52 | PPARD | NA | PPARD Entrez,  Source | peroxisome proliferative activated receptor, delta | 1992 | 0.790 | 0.3022 | Yes |
| 53 | AXIN1 | NA | AXIN1 Entrez,  Source | axin 1 | 2020 | 0.784 | 0.3046 | Yes |
| 54 | FZD2 | NA | FZD2 Entrez,  Source | frizzled homolog 2 (Drosophila) | 2027 | 0.783 | 0.3083 | Yes |
| 55 | TGFBR2 | NA | TGFBR2 Entrez,  Source | transforming growth factor, beta receptor II (70/80kDa) | 2057 | 0.776 | 0.3106 | Yes |
| 56 | EGLN1 | NA | EGLN1 Entrez,  Source | egl nine homolog 1 (C. elegans) | 2121 | 0.762 | 0.3109 | Yes |
| 57 | CCDC6 | NA | CCDC6 Entrez,  Source | coiled-coil domain containing 6 | 2198 | 0.745 | 0.3104 | Yes |
| 58 | EP300 | NA | EP300 Entrez,  Source | E1A binding protein p300 | 2210 | 0.742 | 0.3136 | Yes |
| 59 | WNT3 | NA | WNT3 Entrez,  Source | wingless-type MMTV integration site family, member 3 | 2214 | 0.741 | 0.3172 | Yes |
| 60 | MAP2K2 | NA | MAP2K2 Entrez,  Source | mitogen-activated protein kinase kinase 2 | 2222 | 0.740 | 0.3206 | Yes |
| 61 | RARA | NA | RARA Entrez,  Source | retinoic acid receptor, alpha | 2290 | 0.726 | 0.3205 | Yes |
| 62 | APC2 | NA | APC2 Entrez,  Source | adenomatosis polyposis coli 2 | 2308 | 0.723 | 0.3232 | Yes |
| 63 | RUNX1 | NA | RUNX1 Entrez,  Source | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 2323 | 0.718 | 0.3261 | Yes |
| 64 | WNT4 | NA | WNT4 Entrez,  Source | wingless-type MMTV integration site family, member 4 | 2324 | 0.718 | 0.3297 | Yes |
| 65 | PRKCG | NA | PRKCG Entrez,  Source | protein kinase C, gamma | 2351 | 0.711 | 0.3319 | Yes |
| 66 | STK36 | NA | STK36 Entrez,  Source | serine/threonine kinase 36 (fused homolog, Drosophila) | 2493 | 0.685 | 0.3275 | Yes |
| 67 | DAPK3 | NA | DAPK3 Entrez,  Source | death-associated protein kinase 3 | 2548 | 0.676 | 0.3279 | Yes |
| 68 | FZD9 | NA | FZD9 Entrez,  Source | frizzled homolog 9 (Drosophila) | 2564 | 0.673 | 0.3305 | Yes |
| 69 | BAD | NA | BAD Entrez,  Source | BCL2-antagonist of cell death | 2764 | 0.637 | 0.3225 | Yes |
| 70 | GLI1 | NA | GLI1 Entrez,  Source | glioma-associated oncogene homolog 1 (zinc finger protein) | 2769 | 0.636 | 0.3256 | Yes |
| 71 | RAD51 | NA | RAD51 Entrez,  Source | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 2788 | 0.631 | 0.3278 | Yes |
| 72 | RXRA | NA | RXRA Entrez,  Source | retinoid X receptor, alpha | 2835 | 0.626 | 0.3284 | Yes |
| 73 | AR | NA | AR Entrez,  Source | androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) | 2850 | 0.623 | 0.3307 | Yes |
| 74 | STAT1 | NA | STAT1 Entrez,  Source | signal transducer and activator of transcription 1, 91kDa | 2854 | 0.622 | 0.3337 | Yes |
| 75 | BRCA2 | NA | BRCA2 Entrez,  Source | breast cancer 2, early onset | 2855 | 0.622 | 0.3369 | Yes |
| 76 | CASP3 | NA | CASP3 Entrez,  Source | caspase 3, apoptosis-related cysteine peptidase | 2903 | 0.613 | 0.3374 | Yes |
| 77 | ITGA6 | NA | ITGA6 Entrez,  Source | integrin, alpha 6 | 3033 | 0.591 | 0.3331 | Yes |
| 78 | TGFA | NA | TGFA Entrez,  Source | transforming growth factor, alpha | 3075 | 0.585 | 0.3338 | Yes |
| 79 | CCNE2 | NA | CCNE2 Entrez,  Source | cyclin E2 | 3078 | 0.585 | 0.3367 | Yes |
| 80 | CHUK | NA | CHUK Entrez,  Source | conserved helix-loop-helix ubiquitous kinase | 3103 | 0.582 | 0.3383 | Yes |
| 81 | RALB | NA | RALB Entrez,  Source | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 3111 | 0.580 | 0.3408 | Yes |
| 82 | TRAF2 | NA | TRAF2 Entrez,  Source | TNF receptor-associated factor 2 | 3221 | 0.564 | 0.3376 | No |
| 83 | STAT3 | NA | STAT3 Entrez,  Source | signal transducer and activator of transcription 3 (acute-phase response factor) | 3305 | 0.550 | 0.3357 | No |
| 84 | ETS1 | NA | ETS1 Entrez,  Source | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 3360 | 0.542 | 0.3355 | No |
| 85 | BIRC2 | NA | BIRC2 Entrez,  Source | baculoviral IAP repeat-containing 2 | 3377 | 0.540 | 0.3373 | No |
| 86 | MSH6 | NA | MSH6 Entrez,  Source | mutS homolog 6 (E. coli) | 3643 | 0.505 | 0.3250 | No |
| 87 | ERBB2 | NA | ERBB2 Entrez,  Source | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 3754 | 0.491 | 0.3214 | No |
| 88 | DCC | NA | DCC Entrez,  Source | deleted in colorectal carcinoma | 3852 | 0.480 | 0.3184 | No |
| 89 | ARAF | NA | ARAF Entrez,  Source | v-raf murine sarcoma 3611 viral oncogene homolog | 3865 | 0.479 | 0.3201 | No |
| 90 | STAT5A | NA | STAT5A Entrez,  Source | signal transducer and activator of transcription 5A | 3875 | 0.478 | 0.3221 | No |
| 91 | ABL1 | NA | ABL1 Entrez,  Source | v-abl Abelson murine leukemia viral oncogene homolog 1 | 3889 | 0.477 | 0.3238 | No |
| 92 | MSH2 | NA | MSH2 Entrez,  Source | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | 3945 | 0.468 | 0.3231 | No |
| 93 | GLI2 | NA | GLI2 Entrez,  Source | GLI-Kruppel family member GLI2 | 4010 | 0.460 | 0.3218 | No |
| 94 | WNT2B | NA | WNT2B Entrez,  Source | wingless-type MMTV integration site family, member 2B | 4131 | 0.442 | 0.3173 | No |
| 95 | BRAF | NA | BRAF Entrez,  Source | v-raf murine sarcoma viral oncogene homolog B1 | 4135 | 0.442 | 0.3194 | No |
| 96 | KIT | NA | KIT Entrez,  Source | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 4261 | 0.427 | 0.3146 | No |
| 97 | ARNT2 | NA | ARNT2 Entrez,  Source | aryl-hydrocarbon receptor nuclear translocator 2 | 4346 | 0.417 | 0.3120 | No |
| 98 | PTGS2 | NA | PTGS2 Entrez,  Source | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 4406 | 0.410 | 0.3108 | No |
| 99 | PPARG | NA | PPARG Entrez,  Source | peroxisome proliferative activated receptor, gamma | 4428 | 0.408 | 0.3117 | No |
| 100 | MECOM | NA | 4436 | 0.407 | 0.3133 | No | ||
| 101 | CCND1 | NA | CCND1 Entrez,  Source | cyclin D1 | 4440 | 0.407 | 0.3152 | No |
| 102 | MAX | NA | MAX Entrez,  Source | MYC associated factor X | 4504 | 0.400 | 0.3137 | No |
| 103 | SKP2 | NA | SKP2 Entrez,  Source | S-phase kinase-associated protein 2 (p45) | 4692 | 0.384 | 0.3052 | No |
| 104 | PTCH1 | NA | PTCH1 Entrez,  Source | patched homolog 1 (Drosophila) | 4725 | 0.380 | 0.3053 | No |
| 105 | MAPK3 | NA | MAPK3 Entrez,  Source | mitogen-activated protein kinase 3 | 4770 | 0.376 | 0.3048 | No |
| 106 | RASSF1 | NA | RASSF1 Entrez,  Source | Ras association (RalGDS/AF-6) domain family 1 | 4836 | 0.369 | 0.3030 | No |
| 107 | MSH3 | NA | MSH3 Entrez,  Source | mutS homolog 3 (E. coli) | 4897 | 0.362 | 0.3015 | No |
| 108 | TFG | NA | TFG Entrez,  Source | TRK-fused gene | 5041 | 0.347 | 0.2953 | No |
| 109 | ZBTB16 | NA | ZBTB16 Entrez,  Source | zinc finger and BTB domain containing 16 | 5056 | 0.345 | 0.2962 | No |
| 110 | PIK3R3 | NA | PIK3R3 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) | 5162 | 0.335 | 0.2920 | No |
| 111 | LEF1 | NA | LEF1 Entrez,  Source | lymphoid enhancer-binding factor 1 | 5206 | 0.331 | 0.2913 | No |
| 112 | NRAS | NA | NRAS Entrez,  Source | neuroblastoma RAS viral (v-ras) oncogene homolog | 5250 | 0.327 | 0.2906 | No |
| 113 | TRAF6 | NA | TRAF6 Entrez,  Source | TNF receptor-associated factor 6 | 5263 | 0.326 | 0.2916 | No |
| 114 | SLC2A1 | NA | SLC2A1 Entrez,  Source | solute carrier family 2 (facilitated glucose transporter), member 1 | 5458 | 0.307 | 0.2822 | No |
| 115 | CDKN2B | NA | CDKN2B Entrez,  Source | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 5538 | 0.300 | 0.2793 | No |
| 116 | JAK1 | NA | JAK1 Entrez,  Source | Janus kinase 1 (a protein tyrosine kinase) | 5549 | 0.300 | 0.2803 | No |
| 117 | LAMC1 | NA | LAMC1 Entrez,  Source | laminin, gamma 1 (formerly LAMB2) | 5595 | 0.296 | 0.2793 | No |
| 118 | BMP4 | NA | BMP4 Entrez,  Source | bone morphogenetic protein 4 | 5627 | 0.294 | 0.2790 | No |
| 119 | HSP90AA1 | NA | HSP90AA1 Entrez,  Source | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 5663 | 0.290 | 0.2786 | No |
| 120 | CASP8 | NA | CASP8 Entrez,  Source | caspase 8, apoptosis-related cysteine peptidase | 5677 | 0.288 | 0.2793 | No |
| 121 | CDK4 | NA | CDK4 Entrez,  Source | cyclin-dependent kinase 4 | 5679 | 0.288 | 0.2807 | No |
| 122 | E2F2 | NA | E2F2 Entrez,  Source | E2F transcription factor 2 | 5727 | 0.284 | 0.2795 | No |
| 123 | TPM3 | NA | TPM3 Entrez,  Source | tropomyosin 3 | 5767 | 0.281 | 0.2788 | No |
| 124 | NTRK1 | NA | NTRK1 Entrez,  Source | neurotrophic tyrosine kinase, receptor, type 1 | 5773 | 0.280 | 0.2799 | No |
| 125 | BAX | NA | BAX Entrez,  Source | BCL2-associated X protein | 5783 | 0.280 | 0.2808 | No |
| 126 | FGF5 | NA | FGF5 Entrez,  Source | fibroblast growth factor 5 | 5962 | 0.266 | 0.2722 | No |
| 127 | LAMB4 | NA | LAMB4 Entrez,  Source | laminin, beta 4 | 6080 | 0.256 | 0.2669 | No |
| 128 | TPR | NA | TPR Entrez,  Source | translocated promoter region (to activated MET oncogene) | 6089 | 0.255 | 0.2678 | No |
| 129 | AKT2 | NA | AKT2 Entrez,  Source | v-akt murine thymoma viral oncogene homolog 2 | 6144 | 0.250 | 0.2660 | No |
| 130 | E2F3 | NA | E2F3 Entrez,  Source | E2F transcription factor 3 | 6148 | 0.250 | 0.2671 | No |
| 131 | CTBP1 | NA | CTBP1 Entrez,  Source | C-terminal binding protein 1 | 6266 | 0.239 | 0.2618 | No |
| 132 | TRAF4 | NA | TRAF4 Entrez,  Source | TNF receptor-associated factor 4 | 6282 | 0.238 | 0.2622 | No |
| 133 | FLT3LG | NA | FLT3LG Entrez,  Source | fms-related tyrosine kinase 3 ligand | 6453 | 0.225 | 0.2538 | No |
| 134 | GLI3 | NA | GLI3 Entrez,  Source | GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome) | 6468 | 0.224 | 0.2541 | No |
| 135 | FLT3 | NA | FLT3 Entrez,  Source | fms-related tyrosine kinase 3 | 6470 | 0.224 | 0.2552 | No |
| 136 | RUNX1T1 | NA | RUNX1T1 Entrez,  Source | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 6521 | 0.218 | 0.2535 | No |
| 137 | MMP2 | NA | MMP2 Entrez,  Source | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 6602 | 0.212 | 0.2501 | No |
| 138 | CCNE1 | NA | CCNE1 Entrez,  Source | cyclin E1 | 6772 | 0.198 | 0.2417 | No |
| 139 | TRAF3 | NA | TRAF3 Entrez,  Source | TNF receptor-associated factor 3 | 6934 | 0.185 | 0.2336 | No |
| 140 | MMP1 | NA | MMP1 Entrez,  Source | matrix metallopeptidase 1 (interstitial collagenase) | 7053 | 0.176 | 0.2279 | No |
| 141 | JUP | NA | JUP Entrez,  Source | junction plakoglobin | 7079 | 0.175 | 0.2273 | No |
| 142 | CRKL | NA | CRKL Entrez,  Source | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 7119 | 0.172 | 0.2260 | No |
| 143 | CDK6 | NA | CDK6 Entrez,  Source | cyclin-dependent kinase 6 | 7145 | 0.170 | 0.2255 | No |
| 144 | HIF1A | NA | HIF1A Entrez,  Source | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7212 | 0.166 | 0.2226 | No |
| 145 | FZD3 | NA | FZD3 Entrez,  Source | frizzled homolog 3 (Drosophila) | 7275 | 0.161 | 0.2200 | No |
| 146 | MDM2 | NA | MDM2 Entrez,  Source | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 7289 | 0.160 | 0.2201 | No |
| 147 | FGF9 | NA | FGF9 Entrez,  Source | fibroblast growth factor 9 (glia-activating factor) | 7403 | 0.151 | 0.2145 | No |
| 148 | MITF | NA | MITF Entrez,  Source | microphthalmia-associated transcription factor | 7456 | 0.147 | 0.2123 | No |
| 149 | CDKN1A | NA | CDKN1A Entrez,  Source | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 7523 | 0.143 | 0.2094 | No |
| 150 | PIAS3 | NA | PIAS3 Entrez,  Source | protein inhibitor of activated STAT, 3 | 7532 | 0.142 | 0.2096 | No |
| 151 | RARB | NA | RARB Entrez,  Source | retinoic acid receptor, beta | 7558 | 0.140 | 0.2090 | No |
| 152 | WNT9A | NA | WNT9A Entrez,  Source | wingless-type MMTV integration site family, member 9A | 7636 | 0.134 | 0.2053 | No |
| 153 | FGF10 | NA | FGF10 Entrez,  Source | fibroblast growth factor 10 | 7676 | 0.132 | 0.2038 | No |
| 154 | EPAS1 | NA | EPAS1 Entrez,  Source | endothelial PAS domain protein 1 | 7795 | 0.123 | 0.1978 | No |
| 155 | DAPK2 | NA | DAPK2 Entrez,  Source | death-associated protein kinase 2 | 7895 | 0.115 | 0.1929 | No |
| 156 | FGF6 | NA | FGF6 Entrez,  Source | fibroblast growth factor 6 | 7896 | 0.115 | 0.1934 | No |
| 157 | VEGFA | NA | 7903 | 0.115 | 0.1937 | No | ||
| 158 | AKT1 | NA | AKT1 Entrez,  Source | v-akt murine thymoma viral oncogene homolog 1 | 7922 | 0.113 | 0.1933 | No |
| 159 | MLH1 | NA | MLH1 Entrez,  Source | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) | 7941 | 0.112 | 0.1928 | No |
| 160 | HGF | NA | HGF Entrez,  Source | hepatocyte growth factor (hepapoietin A; scatter factor) | 8193 | 0.093 | 0.1792 | No |
| 161 | FGF11 | NA | FGF11 Entrez,  Source | fibroblast growth factor 11 | 8278 | 0.087 | 0.1750 | No |
| 162 | CTNNA3 | NA | CTNNA3 Entrez,  Source | catenin (cadherin-associated protein), alpha 3 | 8284 | 0.087 | 0.1751 | No |
| 163 | FOXO1 | NA | 8476 | 0.074 | 0.1648 | No | ||
| 164 | FZD7 | NA | FZD7 Entrez,  Source | frizzled homolog 7 (Drosophila) | 8575 | 0.067 | 0.1596 | No |
| 165 | CUL2 | NA | CUL2 Entrez,  Source | cullin 2 | 8605 | 0.065 | 0.1583 | No |
| 166 | DVL2 | NA | DVL2 Entrez,  Source | dishevelled, dsh homolog 2 (Drosophila) | 8664 | 0.060 | 0.1554 | No |
| 167 | PIK3CA | NA | PIK3CA Entrez,  Source | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 8784 | 0.052 | 0.1490 | No |
| 168 | KLK3 | NA | KLK3 Entrez,  Source | kallikrein 3, (prostate specific antigen) | 8820 | 0.050 | 0.1473 | No |
| 169 | COL4A6 | NA | COL4A6 Entrez,  Source | collagen, type IV, alpha 6 | 8853 | 0.047 | 0.1457 | No |
| 170 | WNT16 | NA | WNT16 Entrez,  Source | wingless-type MMTV integration site family, member 16 | 8939 | 0.040 | 0.1412 | No |
| 171 | MTOR | NA | 8951 | 0.039 | 0.1408 | No | ||
| 172 | SUFU | NA | SUFU Entrez,  Source | suppressor of fused homolog (Drosophila) | 9052 | 0.031 | 0.1353 | No |
| 173 | IGF1 | NA | IGF1 Entrez,  Source | insulin-like growth factor 1 (somatomedin C) | 9306 | 0.014 | 0.1212 | No |
| 174 | PIAS1 | NA | PIAS1 Entrez,  Source | protein inhibitor of activated STAT, 1 | 9451 | 0.004 | 0.1132 | No |
| 175 | CKS1B | NA | CKS1B Entrez,  Source | CDC28 protein kinase regulatory subunit 1B | 9735 | -0.001 | 0.0973 | No |
| 176 | MAP2K1 | NA | MAP2K1 Entrez,  Source | mitogen-activated protein kinase kinase 1 | 9745 | -0.001 | 0.0968 | No |
| 177 | RALBP1 | NA | RALBP1 Entrez,  Source | ralA binding protein 1 | 9759 | -0.003 | 0.0961 | No |
| 178 | FGF4 | NA | FGF4 Entrez,  Source | fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene) | 9815 | -0.007 | 0.0931 | No |
| 179 | PDGFB | NA | PDGFB Entrez,  Source | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 9832 | -0.008 | 0.0922 | No |
| 180 | CDKN2A | NA | CDKN2A Entrez,  Source | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 9855 | -0.010 | 0.0910 | No |
| 181 | RAC1 | NA | RAC1 Entrez,  Source | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 9857 | -0.010 | 0.0910 | No |
| 182 | FGF8 | NA | FGF8 Entrez,  Source | fibroblast growth factor 8 (androgen-induced) | 9986 | -0.018 | 0.0839 | No |
| 183 | FGF17 | NA | FGF17 Entrez,  Source | fibroblast growth factor 17 | 9997 | -0.018 | 0.0835 | No |
| 184 | IGF1R | NA | IGF1R Entrez,  Source | insulin-like growth factor 1 receptor | 10119 | -0.027 | 0.0768 | No |
| 185 | MAPK8 | NA | MAPK8 Entrez,  Source | mitogen-activated protein kinase 8 | 10132 | -0.028 | 0.0763 | No |
| 186 | APPL1 | NA | 10235 | -0.033 | 0.0708 | No | ||
| 187 | CRK | NA | CRK Entrez,  Source | v-crk sarcoma virus CT10 oncogene homolog (avian) | 10244 | -0.034 | 0.0705 | No |
| 188 | VHL | NA | VHL Entrez,  Source | von Hippel-Lindau tumor suppressor | 10397 | -0.042 | 0.0622 | No |
| 189 | HDAC2 | NA | HDAC2 Entrez,  Source | histone deacetylase 2 | 10429 | -0.044 | 0.0607 | No |
| 190 | XIAP | NA | 10443 | -0.045 | 0.0602 | No | ||
| 191 | CBLC | NA | CBLC Entrez,  Source | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 10474 | -0.046 | 0.0587 | No |
| 192 | FZD5 | NA | FZD5 Entrez,  Source | frizzled homolog 5 (Drosophila) | 10529 | -0.049 | 0.0559 | No |
| 193 | RET | NA | RET Entrez,  Source | ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) | 10661 | -0.059 | 0.0489 | No |
| 194 | SHH | NA | SHH Entrez,  Source | sonic hedgehog homolog (Drosophila) | 10664 | -0.059 | 0.0491 | No |
| 195 | CBLB | NA | CBLB Entrez,  Source | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 10677 | -0.059 | 0.0487 | No |
| 196 | WNT9B | NA | WNT9B Entrez,  Source | wingless-type MMTV integration site family, member 9B | 10696 | -0.061 | 0.0480 | No |
| 197 | SMAD4 | NA | SMAD4 Entrez,  Source | SMAD, mothers against DPP homolog 4 (Drosophila) | 10712 | -0.062 | 0.0475 | No |
| 198 | DVL3 | NA | DVL3 Entrez,  Source | dishevelled, dsh homolog 3 (Drosophila) | 10751 | -0.063 | 0.0457 | No |
| 199 | FGF3 | NA | FGF3 Entrez,  Source | fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) | 10785 | -0.064 | 0.0442 | No |
| 200 | CTBP2 | NA | CTBP2 Entrez,  Source | C-terminal binding protein 2 | 10837 | -0.067 | 0.0416 | No |
| 201 | PLCG1 | NA | PLCG1 Entrez,  Source | phospholipase C, gamma 1 | 10890 | -0.071 | 0.0391 | No |
| 202 | IKBKB | NA | IKBKB Entrez,  Source | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 10944 | -0.074 | 0.0365 | No |
| 203 | LAMA2 | NA | LAMA2 Entrez,  Source | laminin, alpha 2 (merosin, congenital muscular dystrophy) | 10978 | -0.076 | 0.0350 | No |
| 204 | SMO | NA | SMO Entrez,  Source | smoothened homolog (Drosophila) | 11027 | -0.079 | 0.0327 | No |
| 205 | PIK3R5 | NA | PIK3R5 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 5, p101 | 11049 | -0.081 | 0.0320 | No |
| 206 | NCOA4 | NA | NCOA4 Entrez,  Source | nuclear receptor coactivator 4 | 11050 | -0.081 | 0.0324 | No |
| 207 | WNT5A | NA | WNT5A Entrez,  Source | wingless-type MMTV integration site family, member 5A | 11202 | -0.092 | 0.0244 | No |
| 208 | WNT7A | NA | WNT7A Entrez,  Source | wingless-type MMTV integration site family, member 7A | 11205 | -0.092 | 0.0248 | No |
| 209 | WNT3A | NA | WNT3A Entrez,  Source | wingless-type MMTV integration site family, member 3A | 11289 | -0.097 | 0.0206 | No |
| 210 | PDGFRA | NA | PDGFRA Entrez,  Source | platelet-derived growth factor receptor, alpha polypeptide | 11392 | -0.105 | 0.0154 | No |
| 211 | RBX1 | NA | RBX1 Entrez,  Source | ring-box 1 | 11485 | -0.114 | 0.0108 | No |
| 212 | FZD1 | NA | FZD1 Entrez,  Source | frizzled homolog 1 (Drosophila) | 11515 | -0.116 | 0.0098 | No |
| 213 | BID | NA | BID Entrez,  Source | BH3 interacting domain death agonist | 11556 | -0.119 | 0.0082 | No |
| 214 | PIK3CB | NA | PIK3CB Entrez,  Source | phosphoinositide-3-kinase, catalytic, beta polypeptide | 11650 | -0.127 | 0.0036 | No |
| 215 | STK4 | NA | STK4 Entrez,  Source | serine/threonine kinase 4 | 11685 | -0.130 | 0.0024 | No |
| 216 | LAMA1 | NA | LAMA1 Entrez,  Source | laminin, alpha 1 | 11699 | -0.132 | 0.0023 | No |
| 217 | PTK2 | NA | PTK2 Entrez,  Source | PTK2 protein tyrosine kinase 2 | 11849 | -0.144 | -0.0053 | No |
| 218 | FGF19 | NA | FGF19 Entrez,  Source | fibroblast growth factor 19 | 11913 | -0.149 | -0.0081 | No |
| 219 | FZD6 | NA | FZD6 Entrez,  Source | frizzled homolog 6 (Drosophila) | 11922 | -0.149 | -0.0078 | No |
| 220 | CSF3R | NA | CSF3R Entrez,  Source | colony stimulating factor 3 receptor (granulocyte) | 11935 | -0.150 | -0.0077 | No |
| 221 | WNT5B | NA | WNT5B Entrez,  Source | wingless-type MMTV integration site family, member 5B | 12031 | -0.158 | -0.0122 | No |
| 222 | PTEN | NA | PTEN Entrez,  Source | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 12081 | -0.162 | -0.0141 | No |
| 223 | CDH1 | NA | CDH1 Entrez,  Source | cadherin 1, type 1, E-cadherin (epithelial) | 12145 | -0.168 | -0.0168 | No |
| 224 | PIK3R2 | NA | PIK3R2 Entrez,  Source | phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta) | 12247 | -0.177 | -0.0216 | No |
| 225 | PGF | NA | PGF Entrez,  Source | placental growth factor, vascular endothelial growth factor-related protein | 12272 | -0.179 | -0.0220 | No |
| 226 | SOS1 | NA | SOS1 Entrez,  Source | son of sevenless homolog 1 (Drosophila) | 12302 | -0.183 | -0.0227 | No |
| 227 | FGF16 | NA | FGF16 Entrez,  Source | fibroblast growth factor 16 | 12426 | -0.195 | -0.0286 | No |
| 228 | CDC42 | NA | CDC42 Entrez,  Source | cell division cycle 42 (GTP binding protein, 25kDa) | 12435 | -0.196 | -0.0281 | No |
| 229 | CTNNB1 | NA | CTNNB1 Entrez,  Source | catenin (cadherin-associated protein), beta 1, 88kDa | 12660 | -0.216 | -0.0395 | No |
| 230 | PIAS2 | NA | PIAS2 Entrez,  Source | protein inhibitor of activated STAT, 2 | 12701 | -0.219 | -0.0406 | No |
| 231 | RHOA | NA | RHOA Entrez,  Source | ras homolog gene family, member A | 12705 | -0.219 | -0.0397 | No |
| 232 | CBL | NA | CBL Entrez,  Source | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 12715 | -0.220 | -0.0391 | No |
| 233 | RALGDS | NA | RALGDS Entrez,  Source | ral guanine nucleotide dissociation stimulator | 12778 | -0.226 | -0.0414 | No |
| 234 | VEGFB | NA | VEGFB Entrez,  Source | vascular endothelial growth factor B | 12945 | -0.240 | -0.0495 | No |
| 235 | LAMC3 | NA | LAMC3 Entrez,  Source | laminin, gamma 3 | 12947 | -0.240 | -0.0483 | No |
| 236 | NOS2 | NA | 12973 | -0.243 | -0.0485 | No | ||
| 237 | MMP9 | NA | MMP9 Entrez,  Source | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 13001 | -0.245 | -0.0487 | No |
| 238 | FZD10 | NA | FZD10 Entrez,  Source | frizzled homolog 10 (Drosophila) | 13043 | -0.248 | -0.0498 | No |
| 239 | APC | NA | APC Entrez,  Source | adenomatosis polyposis coli | 13130 | -0.256 | -0.0533 | No |
| 240 | E2F1 | NA | E2F1 Entrez,  Source | E2F transcription factor 1 | 13216 | -0.264 | -0.0567 | No |
| 241 | CTNNA1 | NA | CTNNA1 Entrez,  Source | catenin (cadherin-associated protein), alpha 1, 102kDa | 13267 | -0.269 | -0.0582 | No |
| 242 | LAMB2 | NA | LAMB2 Entrez,  Source | laminin, beta 2 (laminin S) | 13505 | -0.292 | -0.0700 | No |
| 243 | RB1 | NA | RB1 Entrez,  Source | retinoblastoma 1 (including osteosarcoma) | 13520 | -0.294 | -0.0693 | No |
| 244 | MAPK9 | NA | MAPK9 Entrez,  Source | mitogen-activated protein kinase 9 | 13521 | -0.294 | -0.0678 | No |
| 245 | CYCS | NA | CYCS Entrez,  Source | cytochrome c, somatic | 13663 | -0.308 | -0.0741 | No |
| 246 | SMAD3 | NA | SMAD3 Entrez,  Source | SMAD, mothers against DPP homolog 3 (Drosophila) | 13718 | -0.312 | -0.0755 | No |
| 247 | RAC3 | NA | RAC3 Entrez,  Source | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 13740 | -0.315 | -0.0751 | No |
| 248 | MYC | NA | MYC Entrez,  Source | v-myc myelocytomatosis viral oncogene homolog (avian) | 13741 | -0.315 | -0.0735 | No |
| 249 | HDAC1 | NA | HDAC1 Entrez,  Source | histone deacetylase 1 | 13850 | -0.326 | -0.0779 | No |
| 250 | FASLG | NA | FASLG Entrez,  Source | Fas ligand (TNF superfamily, member 6) | 13862 | -0.326 | -0.0769 | No |
| 251 | SPI1 | NA | SPI1 Entrez,  Source | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 13887 | -0.329 | -0.0765 | No |
| 252 | RAF1 | NA | RAF1 Entrez,  Source | v-raf-1 murine leukemia viral oncogene homolog 1 | 13934 | -0.335 | -0.0774 | No |
| 253 | GRB2 | NA | GRB2 Entrez,  Source | growth factor receptor-bound protein 2 | 14005 | -0.345 | -0.0796 | No |
| 254 | HHIP | NA | HHIP Entrez,  Source | hedgehog interacting protein | 14091 | -0.357 | -0.0825 | No |
| 255 | PTCH2 | NA | PTCH2 Entrez,  Source | patched homolog 2 (Drosophila) | 14147 | -0.363 | -0.0838 | No |
| 256 | WNT1 | NA | WNT1 Entrez,  Source | wingless-type MMTV integration site family, member 1 | 14168 | -0.365 | -0.0830 | No |
| 257 | RALA | NA | RALA Entrez,  Source | v-ral simian leukemia viral oncogene homolog A (ras related) | 14203 | -0.368 | -0.0831 | No |
| 258 | WNT2 | NA | WNT2 Entrez,  Source | wingless-type MMTV integration site family member 2 | 14295 | -0.379 | -0.0862 | No |
| 259 | ITGAV | NA | ITGAV Entrez,  Source | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 14332 | -0.383 | -0.0863 | No |
| 260 | MAPK10 | NA | MAPK10 Entrez,  Source | mitogen-activated protein kinase 10 | 14334 | -0.383 | -0.0844 | No |
| 261 | BCL2 | NA | BCL2 Entrez,  Source | B-cell CLL/lymphoma 2 | 14397 | -0.390 | -0.0859 | No |
| 262 | FOS | NA | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 14425 | -0.395 | -0.0854 | No |
| 263 | TGFB3 | NA | TGFB3 Entrez,  Source | transforming growth factor, beta 3 | 14478 | -0.403 | -0.0863 | No |
| 264 | FGF13 | NA | FGF13 Entrez,  Source | fibroblast growth factor 13 | 14593 | -0.418 | -0.0905 | No |
| 265 | VEGFC | NA | VEGFC Entrez,  Source | vascular endothelial growth factor C | 14653 | -0.425 | -0.0917 | No |
| 266 | CDK2 | NA | CDK2 Entrez,  Source | cyclin-dependent kinase 2 | 14672 | -0.427 | -0.0905 | No |
| 267 | FGF20 | NA | FGF20 Entrez,  Source | fibroblast growth factor 20 | 14699 | -0.429 | -0.0898 | No |
| 268 | WNT10B | NA | WNT10B Entrez,  Source | wingless-type MMTV integration site family, member 10B | 14760 | -0.438 | -0.0909 | No |
| 269 | MAPK1 | NA | MAPK1 Entrez,  Source | mitogen-activated protein kinase 1 | 14765 | -0.439 | -0.0889 | No |
| 270 | RASSF5 | NA | RASSF5 Entrez,  Source | Ras association (RalGDS/AF-6) domain family 5 | 14890 | -0.460 | -0.0935 | No |
| 271 | FGF18 | NA | FGF18 Entrez,  Source | fibroblast growth factor 18 | 14949 | -0.468 | -0.0944 | No |
| 272 | STAT5B | NA | STAT5B Entrez,  Source | signal transducer and activator of transcription 5B | 15023 | -0.478 | -0.0961 | No |
| 273 | FH | NA | FH Entrez,  Source | fumarate hydratase | 15028 | -0.479 | -0.0939 | No |
| 274 | WNT8A | NA | WNT8A Entrez,  Source | wingless-type MMTV integration site family, member 8A | 15163 | -0.497 | -0.0989 | No |
| 275 | BIRC5 | NA | BIRC5 Entrez,  Source | baculoviral IAP repeat-containing 5 (survivin) | 15435 | -0.539 | -0.1113 | No |
| 276 | KRAS | NA | KRAS Entrez,  Source | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 15437 | -0.539 | -0.1086 | No |
| 277 | PRKCB | NA | 15489 | -0.550 | -0.1087 | No | ||
| 278 | AXIN2 | NA | AXIN2 Entrez,  Source | axin 2 (conductin, axil) | 15616 | -0.574 | -0.1128 | No |
| 279 | RXRB | NA | RXRB Entrez,  Source | retinoid X receptor, beta | 15636 | -0.578 | -0.1110 | No |
| 280 | GSK3B | NA | GSK3B Entrez,  Source | glycogen synthase kinase 3 beta | 15693 | -0.588 | -0.1111 | No |
| 281 | ARNT | NA | ARNT Entrez,  Source | aryl hydrocarbon receptor nuclear translocator | 15944 | -0.641 | -0.1219 | No |
| 282 | TP53 | NA | TP53 Entrez,  Source | tumor protein p53 (Li-Fraumeni syndrome) | 15988 | -0.654 | -0.1209 | No |
| 283 | TRAF5 | NA | TRAF5 Entrez,  Source | TNF receptor-associated factor 5 | 16085 | -0.677 | -0.1229 | No |
| 284 | COL4A4 | NA | COL4A4 Entrez,  Source | collagen, type IV, alpha 4 | 16105 | -0.682 | -0.1205 | No |
| 285 | WNT8B | NA | WNT8B Entrez,  Source | wingless-type MMTV integration site family, member 8B | 16212 | -0.709 | -0.1228 | No |
| 286 | SOS2 | NA | SOS2 Entrez,  Source | son of sevenless homolog 2 (Drosophila) | 16328 | -0.741 | -0.1255 | No |
| 287 | KITLG | NA | KITLG Entrez,  Source | KIT ligand | 16352 | -0.749 | -0.1230 | No |
| 288 | BMP2 | NA | BMP2 Entrez,  Source | bone morphogenetic protein 2 | 16401 | -0.765 | -0.1218 | No |
| 289 | FGFR2 | NA | FGFR2 Entrez,  Source | ffer syndrome, Jackson-Weiss syndrome) | 16434 | -0.774 | -0.1196 | No |
| 290 | FGF23 | NA | FGF23 Entrez,  Source | fibroblast growth factor 23 | 16437 | -0.775 | -0.1158 | No |
| 291 | SMAD2 | NA | SMAD2 Entrez,  Source | SMAD, mothers against DPP homolog 2 (Drosophila) | 16594 | -0.824 | -0.1204 | No |
| 292 | FGF7 | NA | FGF7 Entrez,  Source | fibroblast growth factor 7 (keratinocyte growth factor) | 16741 | -0.869 | -0.1241 | No |
| 293 | WNT11 | NA | WNT11 Entrez,  Source | wingless-type MMTV integration site family, member 11 | 16831 | -0.900 | -0.1246 | No |
| 294 | CDKN1B | NA | CDKN1B Entrez,  Source | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 16862 | -0.909 | -0.1216 | No |
| 295 | NKX3-1 | NA | NKX3-1 Entrez,  Source | NK3 transcription factor related, locus 1 (Drosophila) | 16875 | -0.915 | -0.1176 | No |
| 296 | ITGB1 | NA | ITGB1 Entrez,  Source | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 16942 | -0.944 | -0.1165 | No |
| 297 | LAMA3 | NA | LAMA3 Entrez,  Source | laminin, alpha 3 | 16986 | -0.962 | -0.1141 | No |
| 298 | FGF12 | NA | FGF12 Entrez,  Source | fibroblast growth factor 12 | 17048 | -0.990 | -0.1125 | No |
| 299 | MET | NA | MET Entrez,  Source | met proto-oncogene (hepatocyte growth factor receptor) | 17207 | -1.062 | -0.1159 | No |
| 300 | LAMB1 | NA | LAMB1 Entrez,  Source | laminin, beta 1 | 17257 | -1.095 | -0.1131 | No |
| 301 | CTNNA2 | NA | CTNNA2 Entrez,  Source | catenin (cadherin-associated protein), alpha 2 | 17310 | -1.125 | -0.1103 | No |
| 302 | CEBPA | NA | CEBPA Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), alpha | 17537 | -1.286 | -0.1164 | No |
| 303 | WNT10A | NA | WNT10A Entrez,  Source | wingless-type MMTV integration site family, member 10A | 17538 | -1.287 | -0.1099 | No |
| 304 | PIK3CG | NA | PIK3CG Entrez,  Source | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 17630 | -1.385 | -0.1079 | No |
| 305 | TCF7L2 | NA | TCF7L2 Entrez,  Source | transcription factor 7-like 2 (T-cell specific, HMG-box) | 17649 | -1.413 | -0.1018 | No |
| 306 | FGF14 | NA | FGF14 Entrez,  Source | fibroblast growth factor 14 | 17654 | -1.419 | -0.0948 | No |
| 307 | CASP9 | NA | CASP9 Entrez,  Source | caspase 9, apoptosis-related cysteine peptidase | 17671 | -1.437 | -0.0884 | No |
| 308 | EGF | NA | EGF Entrez,  Source | epidermal growth factor (beta-urogastrone) | 17704 | -1.472 | -0.0827 | No |
| 309 | WNT6 | NA | WNT6 Entrez,  Source | wingless-type MMTV integration site family, member 6 | 17757 | -1.546 | -0.0778 | No |
| 310 | AKT3 | NA | AKT3 Entrez,  Source | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 17766 | -1.559 | -0.0703 | No |
| 311 | TCF7 | NA | TCF7 Entrez,  Source | transcription factor 7 (T-cell specific, HMG-box) | 17768 | -1.562 | -0.0624 | No |
| 312 | TGFBR1 | NA | TGFBR1 Entrez,  Source | transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa) | 17790 | -1.602 | -0.0554 | No |
| 313 | PLD1 | NA | PLD1 Entrez,  Source | phospholipase D1, phosphatidylcholine-specific | 17808 | -1.634 | -0.0481 | No |
| 314 | EGLN3 | NA | EGLN3 Entrez,  Source | egl nine homolog 3 (C. elegans) | 17889 | -1.826 | -0.0433 | No |
| 315 | FGFR3 | NA | FGFR3 Entrez,  Source | fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) | 17891 | -1.831 | -0.0341 | No |
| 316 | PRKCA | NA | PRKCA Entrez,  Source | protein kinase C, alpha | 17892 | -1.832 | -0.0247 | No |
| 317 | PDGFRB | NA | PDGFRB Entrez,  Source | platelet-derived growth factor receptor, beta polypeptide | 17904 | -1.866 | -0.0159 | No |
| 318 | ITGA2B | NA | ITGA2B Entrez,  Source | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 18009 | -2.323 | -0.0099 | No |
| 319 | CSF1R | NA | CSF1R Entrez,  Source | colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog | 18138 | -3.682 | 0.0016 | No |

